Claritus Pharmaceuticals Inc. (CLAZF)

[djmurdock]

Based on what the CEO told me the interim results were the lowest dosage of CBD treatment. We all know CBD is extremely safe, so the full results are almost a slam dunk. The higher dosage should be even more effective.

Aphria bought millions worth at .40US (yes they sold, but the Aphria Chief Science Officer is still on Kalytera board of directors)

I could easily see this going back to the .40s range soon and way higher if Phase2B are great, which I expect them to be.